REPORT HIGHLIGHT
Cancer Stem Cells Market size was valued at USD 1,056.7 Million in 2022, expanding at a CAGR of 9.1% from 2023 to 2030.
A subgroup of cells having stem cell-like characteristics that are present in tumors are known as cancer stem cells. They have the same capacity for self-renewal and cell cancer forms differentiation as regular stem cells. However, cancer stem cells are tumorigenic, meaning they can give rise to new cancer cells and aid in the spread of disease, in contrast to normal stem cells.
Cancer Stem Cells Market- Market Dynamics:
Growing prevalence of cancer diseases and rising investment in stem cell research is expected to propel the cancer stem cells demand.
The market for cancer stem cells has been significantly influenced by the rising incidence of cancer across the world. Research and treatments involving cancer stem cells are becoming more important as cancer continues to be the leading cause of death worldwide. The rate of new discoveries and the creation of innovative therapies has accelerated due to increased financing and investment in stem cell research, especially cancer stem cells. Nonprofit foundations, for-profit businesses, and government agencies have all contributed to this expansion. Understanding cancer stem cells and their function in tumor initiation and progression has improved because of developments in the fields of genomics, molecular biology, and immunotherapy.
Pharmaceutical corporations are funding clinical trials and research into cancer stem cells to create novel treatments that specifically target these cells. Positive trial outcomes can spur market expansion. Clinical studies are crucial for confirming the security and effectiveness of prospective medicines.
Cancer Stem Cells Market- Key Insights:
- As per the analysis shared by our research analyst, the global Cancer Stem Cells market is estimated to grow annually at a CAGR of around 9.1% over the forecast period (2023-2030)
- The Cancer Stem Cells industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
- Based on Application, targeted cancerous stem cells segment was predicted to show maximum market share in the year 2022.
- Based on Cancer Forms, segmentation, breast cancer segment was the leading in 2022
- On the basis of region, North America was the leading revenue generator in 2022.
Cancer Stem Cells Market- Segmentation Analysis:
The Global Cancer Stem Cells Market is segmented on the basis of Cancer Forms, Application, System, and Region.
The market is divided into seven categories based on Cancer Forms: breast, blood, brain, lung, pancreatic, bladder, and others. The rocket launchers segment dominates the market. Increasing demand rocket launching system is contributing to market growth.
The market is divided into two categories based on Application: targeted cancerous stem cells, and stem-cell based cancer therapy. The targeted cancerous stem cells segment dominates the market. Growing prevalence of small stem cells is expected to boost the market growth.
Cancer Stem Cells Market- Geographical Insights:
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Cancer Stem Cells Market- Competitive Landscape:
Owing to the increasing advancement in healthcare and genetic engineering, which influence the Cancer Stem Cells market. Healthcare facilities including application providers compete on various factors, such as cancer therapy, reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.
Recent Developments:
In June 2022, BlueRock Therapeutics has introduced new cell treatment site in Germany to enhance its clinical capabilities in Europe.
Key features of the study:
- This proposed research study on Cancer Stem Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Cancer Stem Cells market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Cancer Stem Cells market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Cancer Stem Cells market
- Impact of COVID-19 on Cancer Stem Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Cancer Stem Cells market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Cancer Stem Cells market, we have also included competitive landscape and key innovator analysis for the Cancer Stem Cells market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Cancer Stem Cells market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Cancer Stem Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL CANCER STEM CELLS MARKET KEY PLAYERS
- Thermo Fisher Scientific, Inc.
- AbbVie, Inc.
- Merck KGaA
- Bionomics
- Lonza
- Stemline Therapeutics, Inc.
- Miltenyi Biotec
- PromoCell GmbH
- MacroGenics, Inc
- OncoMed Pharmaceuticals, Inc.
- Irvine Scientific
- STEMCELL Technologies Inc.
- BlueRock Therapeutics
- Sino Biological Inc.
- Biotime Inc.
GLOBAL CANCER STEM CELLS MARKET, BY CANCER FORMS
- Breast
- Blood
- Brain
- Lung
- Pancreatic
- Bladder
- Others
GLOBAL CANCER STEM CELLS MARKET, BY APPLICATION
- Targeted Cancerous Stem Cells
- Stem-cell based Cancer Therapy
GLOBAL CANCER STEM CELLS MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA